Drug Shortage Report for MYOCHRYSINE

Last updated on 2019-06-10 History
Report ID 29269
Drug Identification Number 01927612
Brand name MYOCHRYSINE
Common or Proper name Myochrisine 25mg/1ml
Company Name SANOFI-AVENTIS CANADA INC
Active Ingredient(s) GOLD SODIUM THIOMALATE
Strength(s) 25MG
Dosage form(s) SOLUTION
Route of administration INTRAMUSCULAR
Packaging size 5
ATC code M01CB
ATC description SPECIFIC ANTIRHEUMATIC AGENTS
Reason for shortage Shortage of an active ingredient.
Anticipated start date 2017-11-24
Actual start date 2017-12-01
Estimated end date 2019-09-30
Actual end date 2019-06-04
Shortage status Resolved
Updated date 2019-06-10
Company comments The continued global shortage of Myochrysine is due to manufacturing issues with the active ingredient. Consequently Sanofi has decided to discontinue all three strengths of Myochrysine globally.
Health Canada comments
Company contact information email: CAINTERNET@sanofi.com Telephone: 1-800-265-7927

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v24 2019-06-10 French Compare
v23 2019-06-10 English Compare
v22 2019-06-10 French Compare
v21 2019-06-10 English Compare
v20 2018-09-07 French Compare
v19 2018-09-07 English Compare
v18 2018-06-12 French Compare
v17 2018-06-12 English Compare
v16 2018-06-11 French Compare
v15 2018-06-11 English Compare
v14 2018-05-09 French Compare
v13 2018-05-09 English Compare
v12 2018-05-09 English Compare
v11 2018-03-15 French Compare
v10 2018-03-15 English Compare
v9 2018-02-09 French Compare
v8 2018-02-09 English Compare
v7 2017-12-05 French Compare
v6 2017-12-05 English Compare
v5 2017-11-25 English Compare

Showing 1 to 20 of 24